News
Obesity accelerates loss of COVID-19 vaccination immunity, study finds
A new study has found the protection offered by COVID-19 vaccination declines more rapidly in people with severe obesity than in those with normal weight. It suggests that people with obesity are likely to need more frequent booster doses to maintain their immunity.Read more
New study recommends replacing skull section after brain bleed treatment
A new trial has found – where possible – surgeons should replace the removed section of the skull following surgery to treat a form of brain bleed. Researchers say the approach will save patients undergoing skull reconstruction further down the line.Read more
Volunteers needed for new needle-free coronavirus vaccine at CRF
Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against COVID-19.Read more
Cambridge researcher wins prestigious award for rare eye disease gene replacement therapy research
Neuroscience researcher Professor Patrick Yu-Wai-Man has won the 2023 Ludwig von Sallmann Clinician-Scientist Award from the Association for Research in Vision and Ophthalmology (ARVO) Foundation.
The award was given in recognition of Prof Read more
Cambridge researchers honoured at Microbiology Society Annual Awards
Congratulations to Professors Sharon Peacock and Ravindra Gupta who received top awards at the Microbiology Society Annual Awards.
The Microbiology Society awards recognise excellence and are made to those making significant contributions in Read more
Underactive immune response may explain obesity link to COVID-19 severity
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response.Read more
Major funding for Cambridge will help find new cancer treatments
Around £3 million has been awarded to clinicians and scientists in Cambridge to support cancer research and find new treatments. Read more
NICE recommends Cambridge-developed ‘artificial pancreas’ for use on NHS for management of type 1 diabetes
The artificial pancreas for type 1 diabetes – which was developed in Cambridge and supported in trials by the NIHR Cambridge BRC and NIHR Cambridge CRF – could soon be approved for use Read more
Gone fishing: highly accurate test for common respiratory viruses uses DNA as ‘bait’
Research supported by NIHR Cambridge BRC has led to a new test that ‘fishes’ for multiple respiratory viruses at once using single strands of DNA as ‘bait’, giving highly accurate results in under Read more
Artificial pancreas successfully trialled for use by type 2 diabetes patients
Cambridge researchers have successfully trialled an artificial pancreas for people living with type 2 diabetes. Read more
Professor Krishna Chatterjee awarded a CBE
Professor Krishna Chatterjee, director of NIHR Cambridge Clinical Research Facility, has been awarded a CBE in the King’s New Year Honours.Read more
Off-patent liver disease drug could prevent COVID-19 infection
Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future variants of the virus – in research part-funded by the Read more
Blood thinning drug to treat recovery from severe Covid is not effective
A Cambridge-led trial has found that a drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe Covid.Read more
Cambridge researchers listed among world’s most influential researchers
Congratulations to our NIHR Cambridge BRC theme leads who have been named in the Clarivate listings of the ‘world’s most influential researchers.’Read more
Cambridge researchers develop safe, affordable device for prostate cancer diagnosis
A new medical device developed at Addenbrooke’s and supported by the NIHR Cambridge BRC and NIHR Cambridge Clinical Research Facility aims to reduce the risk of infection in prostate patients – and save Read more
High blood pressure is directly linked to severe COVID-19
A new study has shown people with high blood pressure are more likely to be admitted to hospital or die from COVID-19, regardless of other factors such as age, sex, ethnicity or BMI.Read more
World-first trial to transfuse lab-grown red blood cells is underway in Cambridge
Red blood cells that have been grown in a laboratory have now been transfused into another person at the NIHR Cambridge Clinical Research Facility in a world first clinical trial. Read more
Cambridge BRC receives £86.2 million to translate research discoveries into new treatments for patients
The NIHR has awarded £86.2 million to NIHR Cambridge Biomedical Research Centre investigators to continue their ground-breaking research, translating new scientific insights into state-of-the-art diagnostics and treatments to transform healthcare. Read more
Dementia signs detected as early as nine years ahead of diagnosis
Cambridge scientists have shown that it is possible to spot signs of brain impairment in patients as early as nine years before they receive a diagnosis for one of a number of dementia-related diseases.Read more
Referrals to long COVID clinic fell by 79% following roll-out of the vaccine
Referrals to Cambridge’s long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine. Read more
Discover more about the NIHR Cambridge BRC
Contact us by phone, email or web for more information.
Events Calendar
Listing relevant events and training sessions for researchers and members of the public.